0001193125-13-051832.txt : 20130212 0001193125-13-051832.hdr.sgml : 20130212 20130212163801 ACCESSION NUMBER: 0001193125-13-051832 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20130212 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20130212 DATE AS OF CHANGE: 20130212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WELLPOINT, INC CENTRAL INDEX KEY: 0001156039 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 352145715 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16751 FILM NUMBER: 13597720 BUSINESS ADDRESS: STREET 1: 120 MONUMENT CIRCLE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 BUSINESS PHONE: 3174886000 MAIL ADDRESS: STREET 1: 120 MONUMENT CIRCLE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT INC DATE OF NAME CHANGE: 20041130 FORMER COMPANY: FORMER CONFORMED NAME: ANTHEM INC DATE OF NAME CHANGE: 20010730 8-K 1 d485023d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 12, 2013

 

 

WELLPOINT, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Indiana   001-16751   35-2145715

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

120 Monument Circle

Indianapolis, IN 46204

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (317) 488-6000

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Section 5—Corporate Governance and Management.

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(c)

On February 12, 2013, WellPoint, Inc. (the “Company”) announced the appointment of Joseph R. Swedish, age 61, as its Chief Executive Officer, effective March 25, 2013. A copy of the related press release is furnished with this Current Report on Form 8-K as Exhibit 99.1.

Mr. Swedish has served as President and Chief Executive Officer of Trinity Health Corporation, a multi-state integrated health care delivery system which operates 47 hospitals in 10 states, since December 2004. Prior to joining Trinity Health, Mr. Swedish was President and Chief Executive Officer of Centura Health, the largest health care provider in Colorado with 12 hospitals. He has also served as President of the East Florida and Central Florida Divisions for the Hospital Corporation of America from 1994 through 1998. Mr. Swedish has served on the boards of three publicly-traded corporations—Coventry Health Care, Inc. from 2010 to 2013, Cross Country Healthcare, Inc. from 2002 to 2005 and RehabCare Group, Inc. from 2003 to 2005 and on the board of BankFirst, a private community bank in Central Florida, from 1995 to 1999. Mr. Swedish received a bachelor’s degree from the University of North Carolina at Charlotte in 1973 and a master’s degree in health administration from Duke University in 1979.

(e)

In connection with Mr. Swedish being appointed Chief Executive Officer, he and the Company executed an offer letter, dated February 6, 2013 (the “Offer Letter”). The material terms of the Offer Letter are as follows:

 

   

Mr. Swedish will serve as Chief Executive Officer of the Company and will be appointed to the Board, effective upon Mr. Swedish commencing employment with the Company.

 

   

Mr. Swedish will receive an annual base salary of $1,250,000 and will be eligible to receive an annual target incentive bonus opportunity of 150% of his base salary, with a maximum annual incentive bonus opportunity of 300% of his base salary.

 

   

For fiscal year 2013, Mr. Swedish will be awarded equity incentive grants with a target value of $8,000,000 in accordance with the terms and conditions of the Company’s Incentive Compensation Plan, with such equity incentive grants to have the same terms and conditions and be awarded in the same proportion as to forms of equity as awards granted to other senior executives of the Company (stock options, performance units and restricted stock units), except for a minimum of one year of vesting upon a termination without Cause or resignation for Good Reason (as each term is defined in the Executive Agreement Plan (as defined below), as amended by the Form Agreement (as defined below)) and prorated vesting on such a termination of employment after the first year of employment, but subject to applicable performance goals.


   

Beginning in fiscal year 2014 and while Mr. Swedish is employed by the Company, he will be eligible to participate in the Company’s equity incentive plans on the same terms as other senior executives of the Company; provided that for purposes of all of Mr. Swedish’s equity awards, Mr. Swedish will be considered eligible for retirement treatment upon the attainment of age 65.

 

   

As an inducement to joining the Company, Mr. Swedish will receive a grant of restricted shares of Company common stock as soon as practicable following his commencement date with a grant date fair value of $1,500,000. This inducement award will vest in three equal annual installments and, subject to the execution of a release, will vest upon a termination of employment without Cause or a resignation for Good Reason.

 

   

Mr. Swedish will be entitled to a “make whole” payment to replace compensation that he will forfeit in connection with accepting employment with the Company (which is currently estimated to be $3,561,476, with such amount subject to potential decrease to the extent not forfeited or substantiated by Mr. Swedish as forfeited).

 

   

Mr. Swedish is entitled to an annual cash payment equal to $54,000 pursuant to the Directed Executive Compensation Program, provided that such program continues to be maintained by the Company.

 

   

Mr. Swedish and his spouse and eligible dependents will be entitled to participate in any employee benefit plan of the Company, at a level commensurate with Mr. Swedish’s position, subject to satisfying the applicable eligibility requirements therefor.

The Offer Letter also provided that, as of his start date, Mr. Swedish would enter into a Company Form Employment Agreement (the “Form Agreement”), which is substantially in the same form as employment agreements previously publicly filed by the Company for its other executives. As a result of Mr. Swedish entering into the Form Agreement, he is a participant in the WellPoint, Inc. Executive Agreement Plan (the “Executive Agreement Plan”) and subject to the covenants and restrictions contained therein. The Form Agreement has been modified from the Company’s standard form to provide Mr. Swedish with certain employment protections during the first two years of his employment with the Company, including modifications to the definitions of Cause and Good Reason during that period, as well as a limitation on the Company’s authority to eliminate the severance protections in the first two years of Mr. Swedish’s employment with the Company. Subject to certain adjustments as may apply to Mr. Swedish’s restrictive covenants, thereafter he will participate in the Executive Agreement Plan on the same basis as other senior officers of the Company.

The Executive Agreement Plan provides for a severance payment of twice Mr. Swedish’s then current base salary and target incentive bonus in the event of a termination of his employment without Cause or for Good Reason, if such termination is not in connection with a Change in Control and a severance payment equal to three times his then current base salary and target annual incentive bonus if the termination of employment without Cause or for Good Reason is in connection with a Change in Control. In addition, the Executive Agreement Plan provides for accelerated vesting of equity grants upon a Change in Control followed by a termination of employment without Cause or for Good Reason.


Mr. Swedish will be subject to certain restrictive covenants such as confidentiality, non-competition, non-solicitation and non-disparagement during his employment and in certain cases for specified periods of time after the termination of his employment. Breaches of these restrictive covenants will subject him to cessation and recoupment of severance pay and certain other severance benefits as detailed in the Form Agreement.

The above descriptions of the Offer Letter and the Form Agreement are not complete and are qualified entirely by reference to the text of those agreements, which are filed as an exhibit (with the Form Agreement filed as Exhibit A to the Offer Letter) to this Current Report on Form 8-K and are incorporated herein by reference.

Section 7—Regulation FD.

 

Item 7.01 Regulation FD Disclosure.

The Company is reaffirming its net income guidance for full year 2013 to be at least $7.60 per share, including integration costs related to the acquisition of Amerigroup Corporation. Given Mr. Swedish’s appointment as Chief Executive Officer with an effective date of March 25, 2013, the Company is postponing its Investor Day, which had been tentatively planned for February 28, 2013.

All of the information furnished in this report (including Exhibit 99.1 hereto) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and unless expressly set forth by specific reference in such filings, shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, whether made before or after the date hereof and regardless of any general incorporation language in such filings.

Section 9—Financial Statements and Exhibits.

 

Item 9.01. Financial Statements, Pro Forma Financial Information and Exhibits.

 

  (d) Exhibits.

 

Exhibit No.

  

Exhibit

10.1    Offer Letter, by and between WellPoint, Inc., and Joseph R. Swedish, dated as of February 6, 2013.
99.1    Press Release issued by WellPoint, Inc. dated February 12, 2013.


WELLPOINT SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

WellPoint and its representatives may from time to time make written and oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA), including statements in this report, in presentations, press releases, filings with the Securities and Exchange Commission, or SEC, and reports to shareholders and in meetings with analysts and investors. The projections referenced in this report are forward-looking and they are intended to be covered by the safe harbor for “forward-looking statements” provided by PSLRA. Words such as “expect(s)”, “feel(s)”, “believe(s)”, “will”, “may”, “anticipate(s)”, “intend”, “estimate”, “project” and similar expressions are intended to identify forward-looking statements, which generally are not historical in nature. These statements include, but are not limited to, financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include: those discussed and identified in our public filings and those of AMERIGROUP Corporation with the SEC; increased government participation in, or regulation or taxation of health benefits and managed care operations, including, but not limited to, the impact of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; trends in health care costs and utilization rates; our ability to secure sufficient premium rates including regulatory approval for and implementation of such rates; our ability to contract with providers consistent with past practice; our ability to integrate and achieve expected synergies and operating efficiencies in the AMERIGROUP Corporation and the 1-800 CONTACTS, Inc. acquisitions within the expected timeframes or at all and to successfully integrate our operations, as such integrations may be more difficult, time consuming or costly than expected, revenues following the transactions may be lower than expected and operating costs, customer loss and business disruption, including, without limitation, difficulties in maintaining relationships with employees, customers, clients and suppliers, may be greater than expected following the transactions; competitor pricing below market trends of increasing costs; reduced enrollment, as well as a negative change in our health care product mix; risks and uncertainties regarding Medicare and Medicaid programs, including those related to non-compliance with the complex regulations imposed thereon and funding risks with respect to revenue received from participation therein; a downgrade in our financial strength ratings; litigation and investigations targeted at our industry and our ability to resolve litigation and investigations within estimates; medical malpractice or professional liability claims or other risks related to health care services provided by our subsidiaries; risks inherent in selling health care products in the consumer retail market; our ability to repurchase shares of our common stock and pay dividends on our common stock due to the adequacy of our cash flow and earnings and other considerations; non-compliance by any party with the Express Scripts, Inc. pharmacy benefit management services agreement, which could result in financial penalties, our inability to meet customer demands, and sanctions imposed by government entities, including the Centers for Medicare & Medicaid Services; events that result in negative publicity for us or the health benefits industry; failure to effectively maintain and modernize our information systems and e-business organization and to maintain good


relationships with third party vendors for information system resources; events that may negatively affect our license with the Blue Cross and Blue Shield Association; possible impairment of the value of our intangible assets if future results do not adequately support goodwill and other intangible assets; intense competition to attract and retain employees; unauthorized disclosure of member sensitive or confidential information; changes in the economic and market conditions, as well as regulations that may negatively affect our investment portfolios and liquidity; possible restrictions in the payment of dividends by our subsidiaries and increases in required minimum levels of capital and the potential negative effect from our substantial amount of outstanding indebtedness; general risks associated with mergers and acquisitions; various laws and provisions in our governing documents that may prevent or discourage takeovers and business combinations; future public health epidemics and catastrophes; and general economic downturns. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. Except to the extent otherwise required by federal securities law, we do not undertake any obligation to republish revised forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Readers are also urged to carefully review and consider the various disclosures in our SEC reports.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: February 12, 2013

 

    WELLPOINT, INC.
    By:  

/s/ Kathleen S. Kiefer

    Name:   Kathleen S. Kiefer
    Title:   Vice President and Interim Corporate Secretary


EXHIBIT INDEX

 

Exhibit No.

  

Exhibit

10.1    Offer Letter, by and between WellPoint, Inc., and Joseph R. Swedish, dated as of February 6, 2013.
99.1    Press Release issued by WellPoint, Inc. dated February 12, 2013.
EX-10.1 2 d485023dex101.htm EXHIBIT 10.1 Exhibit 10.1

Exhibit 10.1

WELLPOINT

120 Monument Circle

Indianapolis, IN 46204

February 6, 2013

Mr. Joseph R. Swedish

[intentionally omitted]

Re: Offer Letter

Dear Joe:

We are pleased to extend to you our offer to join WellPoint, Inc., an Indiana corporation (the “Company”), as Chief Executive Officer of the Company (the “CEO”). If you accept this offer, your start date will be during the second calendar quarter of 2013 on a date mutually agreed to by you and the Chair of the Board of Directors of the Company (the “Board”), or such earlier date as mutually agreed to by you and the Chair of the Board (such date, the “Start Date”). This letter (“Offer Letter”) serves as confirmation of our offer subject to the contingencies listed below.

Position and Duties. As of the Start Date, you will (1) be employed by the Company as CEO, with such duties as are commensurate with such position and as are customarily exercised by a person holding such position in companies of the size and nature of the Company, (2) report to the Board, (3) be appointed to the Board effective as of the Start Date and be nominated for reelection to the Board in each such year thereafter in which your term as a director is set to expire and such Board service shall be for no additional compensation, (4) serve as a member of the board of directors of any of the Company’s subsidiaries to which you are elected for no additional compensation, and (5) perform your duties primarily at the Company’s headquarters in Indianapolis, Indiana. During your employment with the Company, you will be permitted to (A) serve on civic or charitable boards or committees and (B) serve on one non-competitive for-profit board, so long as such activities do not significantly interfere with the performance of your responsibilities as an officer and employee of the Company in accordance with this Offer Letter.

Base Salary. Your base salary as of the Start Date will be at an annual rate of $1,250,000, which will be paid in substantially equal installments in accordance with the Company’s payroll policies. Your base salary will be reviewed from time to time, but at least annually, by the Board or the Compensation Committee of the Board (the “Compensation Committee”). The base salary as determined herein from time to time shall constitute your “base salary” for all purposes under this Offer Letter.


Annual Incentive. You will be eligible to participate in the Company’s Annual Incentive Plan for fiscal year 2013 with an annual target bonus opportunity equal to 150 percent of your base salary (“Annual Target Bonus”) and an annual maximum bonus opportunity equal to 300 percent of your base salary, prorated for the portion of the year that you are actually employed by the Company during fiscal year 2013, to be paid to you at the same time as annual bonuses are paid to senior executives of the Company generally, but in no event later than two and a half months after the end of the fiscal year. Your Annual Target Bonus will be reviewed from time to time, but at least annually, by the Board or the Compensation Committee.

Equity Incentive Grants. For fiscal year 2013, you will be awarded equity incentive grants with a target value of $8,000,000 (using the same valuation method as is used by the Company for grants of equity awards to other senior executives of the Company generally at such time) in accordance with the terms and conditions of the Company’s Incentive Compensation Plan, provided that the Company may make such grants as an “inducement award” and not expressly pursuant to such plan in which case the Company shall take all actions as are required to satisfy NYSE listing standards applicable to such grants and promptly after such grants shall file a Form S-8 registering the shares of common stock respecting such grants, (the “2013 Awards”). All such awards will be delivered to you on the same terms and conditions and in the same proportion as to the forms of equity award granted as long term incentive compensation awards granted to other senior executives of the Company in fiscal year 2013 generally (i.e., 20% as stock options time-vesting 33-1/3% per year, 50% as performance units time- and performance-vesting 33-1/3% per year and 30% restricted stock units time-vesting 33-1/3% per year), as determined by the Compensation Committee. Notwithstanding the foregoing, upon a termination of your employment by the Company without Cause (as defined below) or a resignation by you for Good Reason (as defined below), subject to your execution and non-revocation of a release as set forth in the Executive Agreement Plan (and not requiring as a condition of any payment hereunder or thereunder your agreement to any restriction on your activities post-termination to which you had not agreed prior to such termination), (1) occurring prior to the first annual vesting date, your 2013 Awards will vest 33.3% effective on the first annual vesting date, subject, in the case of any 2013 Awards subject to performance goals, to the achievement of any such performance goals; (2) occurring after the first annual vesting date, you will vest in a number of 2013 Awards (in addition to such number of awards as may have previously vested), as a result of your termination, subject, in the case of any 2013 Awards subject to performance goals, to the achievement of any such performance goals, equal to the product of (A) the number of shares subject to such 2013 Award scheduled to vest during such year and (B) a fraction, the numerator of which is the number of days from the last annual vesting date through your termination of employment and the denominator of which is 365; and (3) for such termination occurring at any time prior to your attaining age 65, any portion of your 2013 Awards that are stock options and vest as a result of such termination will be exercisable for not less than 45 days from the vesting date. Beginning in fiscal year 2014 and while you continue to be employed by the Company, you will be eligible to participate in the Company’s equity incentive plans as determined by the Compensation Committee in its discretion on terms and conditions comparable to other senior executives of the Company; provided that for purposes of such awards, and for purposes of determining the

 

2


post- employment termination exercise period of the stock options granted under your 2013 Awards, you will be considered to be eligible for retirement treatment upon your attainment of age 65. For purposes of this Offer Letter, “Cause” and “Good Reason” shall have the meaning of those terms set forth in the employment agreement attached hereto as Exhibit A (without regard for any amendment or termination of such employment agreement after expiration of the Initial Term (as defined therein)).

“Make Whole” Payment. In replacement of compensation to be forfeited by you (as previously disclosed to the Company) as a result of your commencing employment with the Company, the Company agrees to pay you an amount in cash equal to $3,561,476 within 30 days following the Start Date (the “Make Whole Payment”). You agree to substantiate the amounts previously disclosed to the Company to the reasonable satisfaction of the Company as soon as practicable following the date hereof. To the extent the substantiation supports a lesser Make Whole Payment, the unsubstantiated amount will be forfeited and, if already paid, refunded by you to the Company. In the event that, within one year following the Start Date, your employment is terminated by the Company for Cause or you resign without Good Reason (and not due to your Disability, as defined in the Company’s Long-Term Disability Plan), you will immediately repay to the Company an amount equal to the product of (A) the after-tax amount of the Make Whole Payment and (B) a fraction, the numerator of which is the number of days from your termination of employment through the first anniversary of the Start Date and the denominator of which is 365. The Make Whole Payment shall not be taken into account for purposes of determining your entitlement under any compensation or benefit plan, program, policy, agreement or other arrangement of the Company or its subsidiaries.

Inducement Grant. Within 30 days of the Start Date, you will be granted a number of restricted shares of the Company’s common stock pursuant to the Incentive Compensation Plan equal to the quotient obtained by dividing $1,500,000 by the Fair Market Value (as defined in the Incentive Compensation Plan) of a share of the Company’s common stock as of the date of grant (the “Inducement Grant”), provided that the Company may make such grants as an “inducement award” and not expressly pursuant to such plan in which case the Company shall take all actions as are required to satisfy the NYSE listing standards applicable to such grants and promptly after such grants shall file a Form S-8 registering the shares of common stock respecting such grants. Subject to your continued employment through each applicable vesting date, one-third of the Inducement Grant shall vest on each of the first three anniversaries of the Start Date. Notwithstanding the foregoing, subject to your execution and non-revocation of a release in accordance with the terms therefor provided above, upon your termination of employment by the Company without Cause or by you for Good Reason or due to your death or Disability, the Inducement Grant shall immediately vest in full.

Other Benefit Plans. You, your spouse and your eligible dependents will be eligible to participate in the employee benefit plans of the Company consistent with your level and role at the Company. In addition, while you are employed by the Company and the Company continues to maintain the Directed Executive Compensation Program, you will be entitled to an annual cash payment equal to $54,000 pursuant to the Directed Executive Compensation Program. The Company will pay or reimburse your

 

3


business expenses incurred in accordance with Company policies applicable to senior executives (or as otherwise may be agreed by the Board in its discretion). You will be entitled to payment of your relocation expenses in accordance with the Company’s homeowner relocation guidelines applicable to senior executives.

Paid Time Off. The Company has a Paid Time Off (“PTO”) policy that provides a bank of paid time for needs such as vacation, personal illness, family needs, etc. You will be eligible for 24 days of PTO annually, which will be prorated during your first year of employment based on the Start Date.

Severance. You will participate in the Company’s Executive Agreement Plan or its successor, as it may be amended from time to time (the “Executive Agreement Plan”). You will enter into an employment agreement effective on your Start Date, pursuant to the Executive Agreement Plan, in the form attached hereto as Exhibit A. The current terms and conditions of the Executive Agreement Plan (as amended) are in the form publicly filed with the Securities and Exchange Commission by the Company as Exhibit 10.4 to the Company’s 2008 annual report (Form 10-K), Exhibit 10.4(a) to the Company’s quarterly report (Form 10-Q) for March 31, 2009 and as Exhibit 10.4(b) the Company’s current report (Form 8-K) dated March 10, 2011.

Company Policies. You will be subject to all policies of the Company, including, without limitation, any stock ownership guidelines and incentive compensation clawback policies applicable to senior executives of the Company, as each policy is adopted or amended from time to time. Consistent with the terms of Company’s stock ownership guidelines, you will have five years to meet the requisite stock ownership level. By signing this Offer Letter you agree that your continued employment is contingent upon compliance with applicable regulatory, registration and licensing requirements, if any, now or in the future required of your position, including passing the appropriate exams or transferring existing license(s), if any, or completing any registration requirements, within any reasonable time limits imposed by the Company, and your compliance with applicable regulatory, registration and licensing.

Representation. You represent and warrant to the Company that, as of the Start Date, you are not a party to any agreement, containing any non-competition or non-solicitation provisions or any other restrictions (including, without limitation, any confidentiality provisions) that would result in any restriction on your ability to accept and perform this or any other position with the Company and its affiliates. Effective as of the Start Date, and prior to your Start Date, you will have resigned as a member of any for-profit boards of directors on which you served prior to the Start Date.

Tax Withholding. The Company may withhold from any amounts payable to you under this Offer Letter or otherwise such United States federal, state or local or foreign taxes as will be required to be withheld pursuant to any applicable law or regulation.

Indemnification. The Company shall, at all times during which you may be subject to liability for your acts and omissions to act occurring while you are an officer

 

4


of the Company or a member of the Board, indemnify you and hold you harmless to the maximum extent permitted under the Company’s charter, by-laws and applicable law and shall cover you as an insured under the Company’s contract of officers and directors liability insurance that covers members of the Board.

Entire Agreement; Amendments; Counterparts. This Offer Letter, and the Executive Agreement Plan and the related employment agreement attached hereto as Exhibit A, each as amended by the Offer Letter, constitute the entire agreement of the parties and supersede all prior agreements. In the event of any inconsistency between any provision of this Offer Letter and any provision of any other plan, program, agreement or other arrangement of the Company, including, without limitation, the Executive Agreement Plan and the related employment agreement, the provisions of this Offer Letter will control. This Offer Letter may be terminated or amended only in a writing signed by the Company and you. This Offer Letter may be executed in separate counterparts, each of which is deemed to be an original and all of which taken together constitute one and the same.

Governing Law and Employment “At Will”. This Offer Letter (and such portions of the employment agreement entered into pursuant to the Executive Agreement Plan as are made applicable under this Offer Letter) and your employment will be governed by Indiana law, without reference to principles of conflict of laws. You and the Company agree that your employment with the Company constitutes “at-will” employment, subject to the above terms of this Offer Letter, and this employment relationship may be terminated at any time, upon written notice to the other party, for any reason, at the option either of you or the Company; provided that you give the Company 30 days’ advance notice of your decision to resign.

[Signature Page Follows Immediately After This Page]

 

5


We are excited about the important contributions you will make to the Company and look forward to your acceptance of our offer. Please indicate your acceptance of these terms by signing below and returning a copy to me by close of business on February 8, 2013.

 

Very truly yours,

 /s/ Ramiro G. Peru

 Name: Ramiro G. Peru
 Title:   Chairman, Compensation Committee WellPoint, Inc. Board of Directors

Accepted and agreed:

 

 /s/ Joseph R. Swedish

JOSEPH R. SWEDISH

Date: February 8, 2013

 

6


EXHIBIT A

Employment Agreement under Executive Agreement Plan

EMPLOYMENT AGREEMENT (the “Agreement”) dated as of             , 2013 (the “Agreement Date”), between WellPoint, Inc., an Indiana corporation (“WellPoint”) with its headquarters and principal place of business in Indianapolis, Indiana (WellPoint, together with its subsidiaries and affiliates are collectively referred to herein as the “Company”), and the person listed on Schedule A (the “Executive”).

W  I  T  N  E  S  S   E  T  H

WHEREAS, the Company desires to retain the services of Executive and to provide Executive an opportunity to receive severance to which Executive is not otherwise entitled in return for the diligent and loyal performance of Executive’s duties and Executive’s agreement to reasonable and limited restrictions on Executive’s post-employment conduct to protect the Company’s investments in its intellectual property, employee workforce, customer relationships and goodwill;

WHEREAS, Executive has entered into an offer letter with the Company, dated February 6, 2013, to which this Agreement is attached as an exhibit and to which this Agreement is subject (“Offer Letter”);

WHEREAS, the Company has established the WellPoint, Inc. Executive Agreement Plan (“Plan”) to provide certain benefits for participants who enter into an employment agreement in the form of this Agreement; and

WHEREAS, Executive is not required to execute this Agreement as a condition of employment; rather, Executive is entering into this Agreement to enjoy the substantial additional payments and benefits available under the Plan and the Designated Plans (as hereinafter defined).

NOW THEREFORE, in consideration of the foregoing, of the mutual promises contained herein and of other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:

1. POSITION/DUTIES.

(a) During the Employment Period (as defined in Section 2 below), Executive shall (1) be employed by the Company in the position set forth on Schedule A, with such duties as are commensurate with such position and duties as set forth in the Offer Letter, (2) report to the Board of Directors of the Company (the “Board”), (3) be appointed to the Board effective as of the Start Date (as defined in the Offer Letter) and nominated for reelection to the Board in each such year thereafter in which Executive’s term as a director is set to expire and such Board service shall be for no additional compensation, (4) serve as a member of the board of directors of any of the Company’s subsidiaries to which Executive is elected for no additional compensation, and (5) perform his duties primarily at the Company’s headquarters in Indianapolis, Indiana.


(b) During the Employment Period, Executive shall comply with Company policies and procedures, and shall devote all of Executive’s business time, energy and skill, best efforts and undivided business loyalty to the performance of Executive’s duties with the Company. Executive further agrees that while employed by the Company he shall not perform any services for remuneration for or on behalf of any other entity without the advance written consent of the Company. Notwithstanding the foregoing, during the Employment Period, Executive will be permitted to (A) serve on civic or charitable boards or committees and (B) serve on one non-competitive for-profit board, so long as such activities do not significantly interfere with the performance of Executive’s responsibilities as an employee and officer of the Company in accordance with this Agreement.

2. EMPLOYMENT PERIOD. Subject to the termination provisions hereinafter provided, the initial term of Executive’s employment under this Agreement shall commence on the Agreement Date listed above and end on the Anniversary Date which is two years after the Agreement Date (the “Initial Term”); provided, however, that commencing on the day following the first anniversary of the Agreement Date the term will automatically be extended each day by one day, until a date (the “Expiration Date”) which is the first annual anniversary of the first date on which either the Company or Executive delivers to the other written notice of non renewal. The term beginning on the Agreement Date and ending on the Expiration Date shall constitute the “Employment Period” for purposes of this Agreement. Expiration of this Agreement shall not be construed to terminate the employment of Executive. If the employment of Executive does not terminate on or before the Expiration Date in accordance with this Agreement, Executive shall continue to be an employee at will of the Company after the Expiration Date unless such employment is otherwise terminated by the Company or Executive.

3. BASE SALARY. The Company agrees to pay Executive a base salary at an annual rate set forth on Schedule A, payable in accordance with the regular payroll practices of the Company. Executive’s Base Salary shall be subject to annual review by the Company. The base salary as determined herein from time to time shall constitute “Base Salary” for purposes of this Agreement.

4. BONUS. During the Employment Period, Executive shall be eligible to receive consideration for an annual bonus upon such terms as adopted from time to time by the Company. The Annual Target Bonus and the Maximum Bonus for which Executive is eligible for the year in which this Agreement is executed is specified in Schedule A to this Agreement, prorated for the portion of the year that Executive is actually employed by the Company during fiscal year 2013.

5. BENEFITS. Executive, his or her spouse and their eligible dependents shall be entitled to participate in any employee benefit plan that the Company has adopted or may adopt, maintain or contribute to for the benefit of its executives at a level commensurate with Executive’s position, subject to satisfying the applicable eligibility requirements therefor, in addition to the benefits available under the Plan. Notwithstanding the foregoing, the Company may modify or terminate any employee benefit plan at any time in accordance with its terms.

 

A-2


6. TERMINATION. Executive’s employment and the Employment Period shall terminate on the first of the following to occur:

(a) DISABILITY. Subject to applicable law, upon 10 days’ prior written notice by the Company to Executive of termination due to Disability. “Disability” shall have the meaning defined in the Company’s Long Term Disability Plan.

(b) DEATH. Automatically on the date of death of Executive.

(c) CAUSE. The Company may terminate Executive’s employment hereunder for Cause immediately upon written notice by the Company to Executive of a termination for Cause. “Cause” shall have the meaning defined for that term in the Plan; provided that, notwithstanding anything in the Plan to the contrary, during the Initial Term, (A) clause (vii) of the “Cause” definition for Executive shall read in its entirety “(vii) conduct which brings the Company into substantial public disgrace or disrepute;” and (B) for purposes of the Cause definition, no act or omission to act will be “willful” if conducted in good faith and with a reasonable belief that such act or omission was in the best interests of the Company.

(d) WITHOUT CAUSE. Upon written notice by the Company to Executive of an involuntary termination without Cause, other than for death or Disability.

(e) BY EXECUTIVE. Upon written notice by Executive to the Company with or without Good Reason as defined in the plan; provided that, notwithstanding anything in the Plan to the contrary, for the Initial Term, (A) the “Good Reason” definition for Executive at any time before or after a Change in Control will include the occurrence of the events set forth in clauses (i), (ii), (iii) or (iv) of the Good Reason definition in the Plan and (B) clause (i) of the Good Reason definition in the Plan for Executive shall read in its entirety “(i) a material reduction during any twenty-four (24) month period in Executive’s Annual Salary, or in Executive’s annual total cash compensation (including Annual Salary and Target Bonus, but excluding for this purpose the one-time “make whole payment” set forth in the Offer Letter).”

7. CONSEQUENCES OF TERMINATION. The Executive’s entitlement to payments and benefits upon termination shall be as set forth in the Plan; provided that, notwithstanding anything in the Plan or elsewhere in this Agreement to the contrary, the provisions set forth in the paragraph titled “Severance” in the Offer Letter shall apply for so long as those provisions are effective in accordance with the terms thereof.

8. RELEASE. Any and all amounts payable and benefits or additional rights provided pursuant to this Agreement beyond Accrued Benefits shall only be payable if Executive delivers to the Company and does not revoke a general release of all claims in a form tendered by the Company which shall be substantially similar to the form attached as Exhibit B to the Plan or such other form acceptable to the Company within thirty (30) days of Executive’s termination of employment.

9. RESTRICTIVE COVENANTS.

(a) CONFIDENTIALITY.

 

A-3


(i) Executive recognizes that the Company derives substantial economic value from information created and used in its business which is not generally known by the public, including, but not limited to, plans, designs, concepts, computer programs, formulae, and equations; product fulfillment and supplier information; customer and supplier lists, and confidential business practices of the Company, its affiliates and any of its customers, vendors, business partners or suppliers; profit margins and the prices and discounts the Company obtains or has obtained or at which it sells or has sold or plans to sell its products or services (except for public pricing lists); manufacturing, assembling, labor and sales plans and costs; business and marketing plans, ideas, or strategies; confidential financial performance and projections; employee compensation; employee staffing and recruiting plans and employee personal information; and other confidential concepts and ideas related to the Company’s business (collectively, “Confidential Information”). Executive expressly acknowledges and agrees that by virtue of his or her employment with the Company, Executive will have access and will use in the course of Executive’s duties certain Confidential Information and that Confidential Information constitutes trade secrets and confidential and proprietary business information of the Company, all of which is the exclusive property of the Company. For purposes of this Agreement, Confidential Information includes the foregoing and other information protected under the Indiana Uniform Trade Secrets Act (the “Act”), or to any comparable protection afforded by applicable law, but does not include information that Executive establishes by clear and convincing evidence, is or may become known to Executive or to the public from sources outside the Company and through means other than a breach of this Agreement.

(ii) Executive agrees that Executive will not for himself or herself or for any other person or entity, directly or indirectly, without the prior written consent of the Company, while employed by the Company and thereafter: (1) use Confidential Information for the benefit of any person or entity other than the Company or its affiliates; (2) remove, copy, duplicate or otherwise reproduce any document or tangible item embodying or pertaining to any of the Confidential Information, except as required to perform Executive’s duties for the Company or its affiliates; or (3) while employed and thereafter, publish, release, disclose or deliver or otherwise make available to any third party any Confidential Information by any communication, including oral, documentary, electronic or magnetic information transmittal device or media. Upon termination of employment, Executive shall return all Confidential Information and all other property of the Company. This obligation of non-disclosure and non-use of information shall continue to exist for so long as such information remains Confidential Information.

(b) DISCLOSURE AND ASSIGNMENT OF INVENTIONS AND IMPROVEMENTS. Without prejudice to any other duties express or implied imposed on Executive hereunder it shall be part of Executive’s normal duties at all times to consider in what manner and by what methods or devices the products, services, processes, equipment or systems of the Company and any customer or vendor of the Company might be improved and promptly to give to the Board or its designee full details of any improvement, invention, research, development, discovery, design, code, model, suggestion or innovation (collectively called “Work Product”), which Executive (alone or with others) may make, discover, create or conceive

 

A-4


in the course of Executive’s employment. Executive acknowledges that the Work Product is the property of the Company. To the extent that any of the Work Product is capable of protection by copyright, Executive acknowledges that it is created within the scope of Executive’s employment and is a work made for hire. To the extent that any such material may not be a work made for hire, Executive hereby assigns to the Company all rights in such material. To the extent that any of the Work Product is an invention, discovery, process or other potentially patentable subject matter (the “Inventions”), Executive hereby assigns to the Company all right, title, and interest in and to all Inventions. The Company acknowledges that the assignment in the preceding sentence does not apply to an Invention that Executive develops entirely on his or her own time without using the Company’s equipment, supplies, facilities or trade secret information, except for those Inventions that either:

 

  (1) relate at the time of conception or reduction to practice of the Invention to the Company’s business, or actual or demonstrably anticipated research or development of the Company, or

 

  (2) result from any work performed by Executive for the Company.

Execution of this Agreement constitutes Executive’s acknowledgment of receipt of written notification of this Section and of notice of the general exception to assignments of Inventions provided under the Uniform Employee Patents Act, in the form adopted by the state having jurisdiction over this Agreement or provision, or any comparable applicable law.

(c) NON-COMPETITION. During the Employment Period, and any period in which Executive is employed by the Company during or after the Employment Period, and during the period of time after Executive’s termination of employment as set forth in Schedule A (the “Restricted Period”), Executive will not, without prior written consent of the Company, directly or indirectly seek or obtain a Competitive Position in a Restricted Territory and perform a Restricted Activity with a Competitor, as those terms are defined herein.

(i) Competitive Position means any employment or performance of services with a Competitor (A) in which Executive has executive level duties for such Competitor, or (B) in which Executive will use any Confidential Information of the Company.

(ii) Restricted Territory means any geographic area in which the Company does business and in which Executive had responsibility for, or Confidential Information about, such business within the thirty six (36) months prior to Executive’s termination of employment from the Company.

(iii) Restricted Activity means any activity for which Executive had responsibility for the Company within the thirty-six (36) months prior to Executive’s termination of employment from the Company or about which Executive had Confidential Information.

(iv) Competitor means any entity or individual (other than the Company), engaged in management of network based managed care plans and programs, or the performance of managed care services, health insurance, long term care insurance, dental, life or disability insurance, behavioral health, vision, flexible spending accounts, COBRA

 

A-5


administration or other products or services substantially the same or similar to those offered by the Company while Executive was employed, or other products or services offered by the Company within twelve (12) months after the termination of Executive’s employment if Executive had responsibility for, or Confidential Information about, such other products or services while Executive was employed by the Company.

(d) NON-SOLICITATION OF CUSTOMERS. During the Restricted Period, Executive will not, either individually or as an employee, partner, consultant, independent contractor, owner, agent, or in any other capacity, directly or indirectly, for a Competitor of the Company as defined in Section 9(c)(iv) above: (i) solicit business from any client or account of the Company or any of its affiliates with which Executive had contact, or responsibility for, or about which Executive had knowledge of Confidential Information by reason of Executive’s employment with the Company, (ii) solicit business from any client or account which was pursued by the Company or any of its affiliates and with which Executive had contact, or responsibility for, or about which Executive had knowledge of Confidential Information by reason of Executive’s employment with the Company, within the twelve (12) month period prior to termination of employment. For purposes of this provision, an individual policyholder in a plan maintained by the Company or by a client or account of the Company under which individual policies are issued, or a certificate holder in such plan under which group policies are issued, shall not be considered a client or account subject to this restriction solely by reason of being such a policyholder or certificate holder.

(e) NON-SOLICITATION OF EMPLOYEES. During the Restricted Period, Executive will not, either individually or as an employee, partner, independent contractor, owner, agent, or in any other capacity, directly or indirectly solicit, hire, attempt to solicit or hire, or participate in any attempt to solicit or hire, for any non-Company affiliated entity, any person who on or during the six (6) months immediately preceding the date of such solicitation or hire is or was an officer or employee of the Company, or whom Executive was involved in recruiting while Executive was employed by the Company.

(f) NON-DISPARAGEMENT. Executive agrees that he or she will not, nor will he or she cause or assist any other person to, make any statement to a third party or take any action which is intended to or would reasonably have the effect of disparaging or harming the Company or the business reputation of the Company’s directors, employees, officers and managers. Further, the Participant will not at any time make any verbal or written statement to any media outlet regarding the Company. The Company agrees not to make any official statement, and to instruct its directors and executive officers not to make any statement or cause or assist any other person to make any statement, to a third party or take any action which is intended to or would reasonably have the effect of disparaging or harming Executive or his business reputation and any such statement by an executive officer of the Company shall be treated by the Company as a breach of the Company’s code of conduct that is subject to discipline of such executive officer up to and including termination of employment.

(g) CESSATION AND RECOUPMENT OF SEVERANCE PAYMENTS AND OTHER BENEFITS. If at any time Executive breaches any provision of this Section 9, then: (i) the Company shall cease to provide any further Severance Pay or other benefits previously received under the Plan and Executive shall repay to the Company all Severance Pay and other

 

A-6


benefits previously received under the Plan, (ii) all unexercised Company stock options under any Designated Plan (as defined in the Plan) whether or not otherwise vested shall cease to be exercisable and shall immediately terminate; (iii) Executive shall forfeit any outstanding restricted stock or other outstanding equity award made under any Designated Plan and not otherwise vested on the date of breach; and (iv) Executive shall pay to the Company (A) for each share of common stock of the Company (“Common Share”) acquired on exercise of an option under a Designated Plan within the 24 months prior to such breach, the excess of the fair market value of a Common Share on the date of exercise over the exercise price, and (B) for each Share of restricted stock that became vested under any Designated Plan within the 24 months prior to such breach, the fair market value (on the date of vesting) of a Common Share. Any amount to be repaid pursuant to this Section 9(g) shall be held by Executive in constructive trust for the benefit of the Company and shall, upon written notice from the Company, within 10 days of such notice, be paid by Executive to the Company with interest from the date such Common Share was acquired or the share of restricted stock became vested, as the case may be, to the date of payment, at 120% of the applicable federal rate, determined under Section 1274(d) of the Internal Revenue Code of 1986, as amended from time to time (the “Code”). Any amount described in clauses (i), (ii) or (iii) that Executive forfeits as a result of a breach of the provisions of Sections 9 shall not reduce any money damages that would be payable to the Company as compensation for such breach. The amount to be repaid pursuant to this Section 9(g) shall be determined on a gross basis, without reduction for any taxes incurred, as of the date of the realization event, and without regard to any subsequent change in the fair market value of a Common Share. The Company shall have the right to offset such gain against any amounts otherwise owed to Executive by the Company (whether as wages, vacation pay, or pursuant to any benefit plan or other compensatory arrangement other than any amount pursuant to any nonqualified deferred compensation plan under Section 409A of the Code). For purposes of this Section 9(g), a “Designated Plan” is each annual bonus and incentive plan, stock option, restricted stock, or other equity compensation or long-term incentive compensation plan, deferred compensation plan, or supplemental retirement plan, listed on Exhibit C to the Plan. The provisions of this Section 9(g) shall apply to awards described in clauses (i), (ii), (iii) and (iv) of this Section earned or made after the date Executive becomes a participant in the Plan and executes this Agreement, and to awards earned or made prior thereto which by their terms are subject to cessation and recoupment under terms similar to those of this paragraph.

(h) EQUITABLE RELIEF AND OTHER REMEDIES—CONSTRUCTION.

(i) Executive acknowledges that each of the provisions of this Agreement are reasonable and necessary to preserve the legitimate business interests of the Company, its present and potential business activities and the economic benefits derived therefrom; that they will not prevent him or her from earning a livelihood in Executive’s chosen business and are not an undue restraint on the trade of Executive, or any of the public interests which may be involved.

(ii) Executive agrees that beyond the amounts otherwise to be provided under this Agreement and the Plan, the Company will be damaged by a violation of this Agreement and the amount of such damage may be difficult to measure. Executive agrees that if Executive commits or threatens to commit a breach of any of the covenants and agreements contained in Sections 9 and 10 to the extent permitted by applicable law,

 

A-7


then the Company shall have the right to seek and obtain all appropriate injunctive and other equitable remedies, without posting bond therefor, except as required by law, in addition to any other rights and remedies that may be available at law or under this Agreement, it being acknowledged and agreed that any such breach would cause irreparable injury to the Company and that money damages would not provide an adequate remedy. Further, if Executive violates Section 9(b)—(e) hereof Executive agrees that the period of violation shall be added to the Period in which Executive’s activities are restricted.

(iii) Notwithstanding the foregoing, the Company will not seek injunctive relief to prevent an Executive residing in California from engaging in post termination competition in California under Section 9(c) or 9(d) of this Agreement provided that the Company may seek and obtain relief to enforce Section 9(g) of this Section with respect to such Executives.

(iv) The parties agree that the covenants contained in this Agreement are severable. If an arbitrator or court shall hold that the duration, scope, area or activity restrictions stated herein are unreasonable under circumstances then existing, the parties agree that the maximum duration, scope, area or activity restrictions reasonable and enforceable under such circumstances shall be substituted for the stated duration, scope, area or activity restrictions to the maximum extent permitted by law. The parties further agree that the Company’s rights under Section 9(g) should be enforced to the fullest extent permitted by law irrespective of whether the Company seeks equitable relief in addition to relief provided thereon or if the arbitrator or court deems equitable relief to be inappropriate.

(i) SURVIVAL OF PROVISIONS. The obligations contained in this Section 9 above and Section 10 below shall survive the cessation of the Employment Period and Executive’s employment with the Company and shall be fully enforceable thereafter; provided, however, (a) if the Plan is terminated or this Agreement expires after the Initial Term, the Restricted Period will expire, and (b) if the severance period under the Plan is reduced following the Initial Term or Base Salary or Annual Target Bonus is excluded as a component of severance in a manner that has the same economic effect as a reduction in the severance period, the duration of the Restricted Period will be reduced to the duration of the severance period.

10. COOPERATION. While employed by the Company and for two years (or, if longer, for so long as any claim referred to in Section 3.10 of the Plan remains pending) after the termination of Executive’s employment for any reason, Executive will provide cooperation and assistance to the Company as provided in Section 3.10 of the Plan.

11. NOTIFICATION OF EXISTENCE OF AGREEMENT. Executive agrees that in the event that Executive is offered employment with another employer (including service as a partner of any partnership or service as an independent contractor) at any time during the existence of this Agreement, or such other period in which post termination obligations of this Agreement apply, Executive shall immediately advise said other employer (or partnership) of the existence of this Agreement and shall immediately provide said employer (or partnership or service recipient) with a copy of Sections 9 and 10 of this Agreement.

 

A-8


12. NOTIFICATION OF SUBSEQUENT EMPLOYMENT. Executive shall report promptly to the Company any employment with another employer (including service as a partner of any partnership or service as an independent contractor or establishment of any business as a sole proprietor) obtained during the period in which Executive’s post termination obligations set forth in Section 9(b)—(f) apply.

13. NOTICE. For the purpose of this Agreement, notices and all other communications provided for in this Agreement shall be in writing and shall be deemed to have been duly given (i) on the date of delivery if delivered by hand, (ii) on the date of transmission, if delivered by confirmed facsimile or e-mail, (iii) on the first business day following the date of deposit if delivered by guaranteed overnight delivery service, or (iv) on the fourth business day following the date delivered or mailed by United States registered or certified mail, return receipt requested, postage prepaid, addressed as follows:

If to Executive:

At the address (or to the facsimile number) shown

on the records of the Company

If to the Company:

Randal L. Brown

Executive Vice President and Chief Human Resources Officer

WellPoint, Inc.

120 Monument Circle

Indianapolis, IN 46204

or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notices of change of address shall be effective only upon receipt.

14. SECTION HEADINGS; INCONSISTENCY. The section headings used in this Agreement are included solely for convenience and shall not affect, or be used in connection with, the interpretation of this Agreement. Capitalized terms not defined hereunder or made applicable under the Offer Letter shall have the meaning set forth in the Plan. In the event of any inconsistency between any provision of the Offer Letter and any provision of any other plan, program, agreement or other arrangement of the Company, including, without limitation, this Agreement and the Plan, the provisions of the Offer Letter will control. For so long as, and to the extent that, the Offer Letter applies and any terms of this Agreement apply pursuant to the Offer Letter, in the event of any inconsistency between any provision of this Agreement and the Plan, the provisions of this Agreement shall control.

15. SUCCESSORS AND ASSIGNS—BINDING EFFECT. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns, as the case may be. The Company may assign this Agreement to any affiliate of the Company and to any successor or assign of all or a substantial portion of the Company’s business. Executive may not assign or transfer any of his rights or obligations under this Agreement. This Agreement, and the Offer Letter constitute the entire agreement of the parties and supersede all prior agreements. This Agreement may be executed in separate counterparts, each of which is deemed to be an original and all of which taken together constitute one and the same.

 

A-9


16. SEVERABILITY. The provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not affect the validity or enforceability of the other provisions hereof.

17. DISPUTE RESOLUTION.

(a) In the event of any dispute arising out of or relating to this Agreement the determinations of fact and the construction of this Agreement or any other determination by the Committee in its sole and absolute discretion pursuant to Section 6.3 of the Plan shall be final and binding on all persons and may not be overturned in any arbitration or any other proceeding unless the party challenging the Committee’s determination can demonstrate by clear and convincing evidence that a determination of fact is clearly erroneous or any other determination by the Committee is arbitrary and capricious; provided, however, that if a claim relates to benefits due following a Change in Control (as defined in the Plan), the Committee’s determination shall not be final and binding if the party challenging the Committee’s determination establishes by a preponderance of the evidence that he or she is entitled to the benefit in dispute.

(b) Any dispute arising out of or relating to this Agreement shall first be presented to the Committee pursuant to the claims procedure set forth in Section 5.2 of the Plan and the claims review procedure of Section 5.3 of the Plan within the times therein provided. In the event of any failure timely to use and exhaust such claims procedure, and the claims review procedures, the decision of the Committee on any matter respecting this Agreement shall be final and binding and may not be challenged by further arbitration, or any other proceeding.

(c) Any dispute arising out of or relating to this Agreement, including the breach, termination or validity thereof, which has not been resolved as provided in paragraph (b) of this Section as provided herein shall be finally resolved by arbitration in accordance with the CPR Rules for Non-Administered Arbitration then currently in effect, by a sole arbitrator. The Company shall be initially responsible for the payment of any filing fee and advance in costs required by CPR or the arbitrator, provided, however, if Executive initiates the claim, Executive will contribute an amount not to exceed $250.00 for these purposes. During the arbitration, each Party shall pay for its own costs and attorneys fees, if any. Attorneys fees and costs should be awarded by the arbitrator to the prevailing party pursuant to Section 19 below.

(d) The arbitration shall be governed by the Federal Arbitration Act, 9 U.S.C. §§ 1-16, and judgment upon the award rendered by the arbitrator may be entered by any court having jurisdiction thereof. The arbitrator shall not have the right to award speculative damages or punitive damages to either party except as expressly permitted by statute (notwithstanding this provision by which both parties hereto waive the right to such damages) and shall not have the power to amend this Agreement. The arbitrator shall be required to follow applicable law. The place of arbitration shall be Indianapolis, Indiana. Any application to enforce or set aside the arbitration award shall be filed in a state or federal court located in Indianapolis, Indiana.

(e) Any demand for Arbitration must be made or any other proceeding filed within six (6) months after the date of the Committee’s decision on review pursuant to Section 5.3 of the Plan.

 

A-10


(f) Notwithstanding the foregoing provisions of this Section, an action to enforce this Agreement shall be filed within eighteen (18) months after the party seeking relief had actual or constructive knowledge of the alleged violation of this Agreement or any party shall be able to seek immediate, temporary, or preliminary injunctive or equitable relief from a court of law or equity if, in its judgment, such relief is necessary to avoid irreparable damage. To the extent that any party wishes to seek such relief from a court, the parties agree to the following with respect to the location of such actions. Such actions brought by Executive shall be brought in a state or federal court located in Indianapolis, Indiana. Such actions brought by the Company shall be brought in a state or federal court located in Indianapolis, Indiana; Executive’s state of residency; or any other forum in which Executive is subject to personal jurisdiction. Executive specifically consents to personal jurisdiction in the State of Indiana for such purposes.

(g) IF FOR ANY REASON THIS ARBITRATION CLAUSE BECOMES NOT APPLICABLE, THEN EACH PARTY, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY AS TO ANY ISSUE RELATING HERETO IN ANY ACTION, PROCEEDING, OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER MATTER INVOLVING THE PARTIES HERETO.

18. GOVERNING LAW. This Agreement forms part of an employee benefit plan subject to the Employee Retirement Income Security Act of 1974 (“ERISA”), and shall be governed by and construed in accordance with ERISA and, to the extent applicable and not preempted by ERISA, the law of the State of Indiana applicable to contracts made and to be performed entirely within that State, without regard to its conflicts of law principles. Any reference to the “Chief Executive Officer” under the Plan will be considered to refer to the Compensation Committee of the Board of Directors of the Company as the Plan applies to Executive.

19. ATTORNEYS’ FEES. In the event of any contest arising under or in connection with this Agreement, the arbitrator or court, as applicable, shall award the prevailing party attorneys’ fees and costs to the extent permitted by applicable law.

20. MISCELLANEOUS. No provision of this Agreement may be modified, waived or discharged unless such waiver, modification or discharge is agreed to in writing and signed by Executive and such officer or director as may be designated by the Company. No waiver by either party hereto at any time of any breach by the other party hereto of, or compliance with, any condition or provision of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time. This Agreement and the Plan and together with all exhibits thereto sets forth the entire agreement of the parties hereto in respect of the subject matter contained herein. No agreements or representations, oral or otherwise, express or implied, with respect to the subject matter hereof have been made by either party which are not expressly set forth in this Agreement.

21. OTHER EMPLOYMENT ARRANGEMENTS. Except for the Offer Letter or as set forth on Schedule A or provided in Section 2.1(a)(i) of the Plan, any severance or change in control plan or agreement (other than the Plan) or other similar agreements or arrangements between Executive and the Company, shall, effective as of the Effective Date, be superseded by this Agreement and the Plan and shall therefore terminate and be null and void and of no force or effect.

 

A-11


IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first written above.

 

WELLPOINT, INC.

By:

 

 

Name:

 

 

Its:

 

 

Date:

 

 

EXECUTIVE

 

Date:

 

 

 

A-12


SCHEDULE A

 

1. Name of Executive    Joseph R. Swedish
2. Position    Chief Executive Officer
3. Base Salary    $1,250,000
4. Annual Target Bonus and Maximum Bonus Opportunity    150% and 300% of Base Salary
5. Severance Payments and Benefits in the case of a Termination Without Cause or With Good Reason and in the absence of a Change in Control to be paid over the period indicated at times corresponding with the Company’s normal payroll dates    24 months base salary and bonus and benefit continuation per the Plan
6. Severance Payments and Benefits in the case of a Termination Without Cause during an Imminent Change in Control Period or during the thirty-six (36) month period after a Change in Control or a Termination by Executive with Good Reason during the thirty six (36) month period after a Change in Control    36 months base salary and bonus and benefit continuation per the Plan
7. Non Solicitation and Non Competition Period following Termination of Employment for any reason    18 months
EX-99.1 3 d485023dex991.htm EXHIBIT 99.1 Exhibit 99.1

Exhibit 99.1

PRESS RELEASE

 

LOGO

WellPoint Names Swedish Chief Executive Officer

Experienced Health Care Executive Selected to Lead Organization

INDIANAPOLIS—February 12, 2013—WellPoint, Inc. (NYSE: WLP) today announced that its board of directors has elected Joseph Swedish as the company’s new chief executive officer, effective March 25, 2013. Swedish, 61, who most recently served as President and Chief Executive Officer for Trinity Health Corporation, succeeds interim chief executive officer John Cannon. Cannon will remain with WellPoint, and in addition to his role as Executive Vice President of Legal & Public Affairs he will help guide the transition, providing continuity and operational leadership.

“Joe embodies the leadership and visionary qualities we value in our chief executive, and the board is confident that under his leadership we will achieve our full potential for future growth and success,” said Jackie M. Ward, chair of the WellPoint Board of Directors. “He brings to WellPoint an extensive track record leading large, complex health care organizations through diverse challenges in difficult market and regulatory environments, and his experience will be invaluable to WellPoint as we continue to find innovative ways to collaborate with providers in an effort to improve quality outcomes and reduce the cost of care. Joe’s background, in concert with our management’s insurance market expertise, creates a team uniquely qualified to manage all facets of our evolving health care system.

“In 24 years as a CEO, he has had tremendous success growing and advancing health care systems by improving core operations, initiating financial restructurings, and expertly integrating strategic mergers and acquisitions,” Ward said. “He is an agile leader at a time when major transformations are requiring health benefit companies to examine new ways to better serve our stakeholders.”

Ward concluded, “I’d like to thank John Cannon for his extraordinary contributions to WellPoint throughout his tenure as interim CEO. John took important steps over the past five and a half months to improve WellPoint’s execution, increase shareholder value, refine the company’s strategy and reorganize our core operations to better support our strategic growth opportunities. This has created a strong, positive momentum in our operations that Joe will build on in the months and years to come.”

“I am honored to be chosen to lead WellPoint,” said Swedish. “Having spent my entire career in health care, I have a strong sense of the market in which the company operates and I am energized by the dynamic changes currently taking place in the industry. I’m committed to ensuring that WellPoint remains a market leader, and I look forward to working with my new colleagues to profitably grow and enhance this organization in a changing market environment.”

Swedish has 40 years’ experience in health care, holding senior executive positions at multi-institutional health care systems, university- and community-based academic medical centers, integrated delivery


systems and regional rural referral hospitals. He most recently served as President and Chief Executive Officer of Trinity Health Corporation, a multi-state integrated health care delivery system which operates 47 hospitals in 10 states, since December 2004.

While at Trinity, he accelerated financial and operational performance, growing revenue from less than $6 billion in 2005 to approximately $9 billion in 2012 and doubling operating margins. He vastly streamlined Trinity’s health care delivery by improving clinical and business processes and integrating IT platforms hard wired in evidence-based best practices. He also spearheaded the “Lead the Way and Find a Way” health care reform campaign that advocated for systematic health care delivery changes based on principles of advancing health care reform. In this role, he has worked closely with multiple bipartisan congressional delegations to actively influence health reform discussions. In 2011, he engineered a successful acquisition of Loyola University Health System – Chicago, and recently signed the definitive agreement for a merger with Catholic Health East, which will make the new organization the fifth-largest U.S.-based health system, serving 21 states with $13 billion in revenues.

Prior to joining Trinity Health, Swedish was President and CEO of Centura Health, the largest health care provider in Colorado. He has also served as President of the East Florida and Central Florida Divisions for the Hospital Corporation of America from 1994 through 1998. He earned his bachelor’s degree from the University of North Carolina at Charlotte and his master’s degree in health administration from Duke University.

Swedish has served on the boards of three publicly-traded corporations: Coventry Health Care, Inc. from 2010 to 2013; Cross Country Health care, Inc. from 2002 to 2005; and RehabCare Group, Inc., from 2003 to 2005. He is Chairman-elect of the 2013 Health Care Systems Governing Council of the American Hospital Association as well as past chairman of the Medicare Wage Index Task Force and a member of the Equity of Care Council. In addition, he is Chairman of the Catholic Health Association and Director of Loyola University Chicago, the National Quality Forum and the Health Care Education Trust.

WellPoint Contacts:

 

Investor Relations

  

Media

Doug Simpson, 212-476-1473    Kristin Binns, 917-697-7802

About WellPoint, Inc.

At WellPoint, we believe there is an important connection between our members’ health and well-being—and the value we bring our customers and shareholders. So each day we work to improve the health of our members and their communities. And, we can make a real difference since we have more than 36 million people in our affiliated health plans, and nearly 67 million people served through our subsidiaries. As an independent licensee of the Blue Cross and Blue Shield Association, WellPoint serves members as the Blue Cross licensee for California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (as the Blue Cross Blue Shield licensee in 10 New York City metropolitan and surrounding counties and as the Blue Cross or Blue Cross Blue Shield licensee in selected upstate counties only), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.), and Wisconsin. In a majority of these service areas, WellPoint’s plans do business as Anthem Blue


Cross, Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Georgia and Empire Blue Cross Blue Shield, or Empire Blue Cross (in the New York service areas). WellPoint also serves customers throughout the country as UniCare and in certain markets through our Amerigroup and CareMore subsidiaries. Our 1-800 CONTACTS, Inc. subsidiary offers customers online sales of contact lenses, eyeglasses and other ocular products. Additional information about WellPoint is available at www.wellpoint.com.

SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

WellPoint and its representatives may from time to time make written and oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA), including statements in this press release, in presentations, filings with the Securities and Exchange Commission, or SEC, reports to shareholders and in meetings with analysts and investors. The projections referenced in this press release are forward-looking and they are intended to be covered by the safe harbor for “forward-looking statements” provided by PSLRA. Words such as “expect(s)”, “feel(s)”, “believe(s)”, “will”, “may”, “anticipate(s)”, “intend”, “estimate”, “project” and similar expressions are intended to identify forward-looking statements, which generally are not historical in nature. These statements include, but are not limited to, financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include: those discussed and identified in the public filings that we and AMERIGROUP Corporation have made with the SEC; increased government participation in, or regulation or taxation of, health benefits and managed care operations, including, but not limited to, the impact of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; trends in health care costs and utilization rates; our ability to secure sufficient premium rates including regulatory approval for and implementation of such rates; our ability to contract with providers consistent with past practice; our ability to integrate and achieve expected synergies and operating efficiencies in the AMERIGROUP Corporation and 1-800 CONTACTS, Inc. acquisitions within the expected timeframes or at all and to successfully integrate our operations, as such integrations may be more difficult, time consuming or costly than expected, revenues following the transactions may be lower than expected and operating costs, customer loss and business disruption, including, without limitation, difficulties in maintaining relationships with employees, customers, clients and suppliers, may be greater than expected following the transactions; competitor pricing below market trends of increasing costs; reduced enrollment, as well as a negative change in our health care product mix; risks and uncertainties regarding Medicare and Medicaid programs, including those related to non-compliance with the complex regulations imposed thereon and funding risks with respect to revenue received from participation therein; a downgrade in our financial strength ratings; litigation and


investigations targeted at our industry and our ability to resolve litigation and investigations within estimates; medical malpractice or professional liability claims or other risks related to health care services provided by our subsidiaries; risks inherent in selling health care products in the consumer retail market; our ability to repurchase shares of our common stock and pay dividends on our common stock due to the adequacy of our cash flow and earnings and other considerations; non-compliance by any party with the Express Scripts, Inc. pharmacy benefit management services agreement, which could result in financial penalties, our inability to meet customer demands, and sanctions imposed by governmental entities, including the Centers for Medicare and Medicaid Services; events that result in negative publicity for us or the health benefits industry; failure to effectively maintain and modernize our information systems and e-business organization and to maintain good relationships with third party vendors for information system resources; events that may negatively affect our licenses with the Blue Cross and Blue Shield Association; possible impairment of the value of our intangible assets if future results do not adequately support goodwill and other intangible assets; intense competition to attract and retain employees; unauthorized disclosure of member sensitive or confidential information; changes in the economic and market conditions, as well as regulations that may negatively affect our investment portfolios and liquidity; possible restrictions in the payment of dividends by our subsidiaries and increases in required minimum levels of capital and the potential negative effect from our substantial amount of outstanding indebtedness; general risks associated with mergers and acquisitions; various laws and provisions in our governing documents that may prevent or discourage takeovers and business combinations; future public health epidemics and catastrophes; and general economic downturns. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. Except to the extent otherwise required by federal securities law, we do not undertake any obligation to republish revised forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Readers are also urged to carefully review and consider the various disclosures in our SEC reports.

GRAPHIC 4 g485023wellpoint.jpg GRAPHIC begin 644 g485023wellpoint.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`,`"M`P$1``(1`0,1`?_$`*<```(!!`,!```````` M```````)"`4&!PH"`P0!`0`!!0$!`0$``````````````00%!@<""`,)$``` M!P`!!`(`!00!!0$````!`@,$!08'"``1$@DA$S%1%!4602(C"B1A@:'!\1<1 M``(!`P,"`P4'`P$##0````$"`P`1!"$%!C$201,'46%QD12!H2(R0B,(L5(5 M,]$T"<'A\6)RDJ)#4R0E-1;_V@`,`P$``A$#$0`_`-_CHHHZ**.BBCHHHZ** M.BBCHHH$>WR/X=%'6N(F*'XB'_W\.DN+]OC27M?W4>90`!\@^?P_Z]*-38=: M"0.I%1(V_G=Q!X[`]2U[D1F%2E&`'_45HMD:SUP* MP$O*/T8V*-/&7?!/QT2Y>+%*H\49E20`1.H!2`8P5_'YWLN5FIAP).T;FWF= MA[![B??X5Z-WK_AX^OW'^'Y7)=VEV"/=\;'><[6N0[HHOY2 MS.[>'2U.R3.!B$'R`1$A1'L(#W[E`>X"'P(#UTFWV5X36Y0$WZ>.A^ MVW0^ZNSHI:.BBCHHHZ**.BBCHHHZ**.BBCHHHZ**.BBCHHHZ**.BBCHHHZ** MPER(N^EYMD=IOF2YV;7+E50CIA',6ST\;-7B&:R34;'!5:0*59)M;5H(7"D: M"J2R2[M,B)B#]@"#?*ER(,:2?%A,\Z+<("%+>VQ.E[:Z]>E6[@>S<7Y'RW!X M]S#=$V79,Z7R#G.A>+&DD4B&6=05/D"7L$K!@40E[_AI.COV6^QG;$@B^+OJ M]T.`!K]?ZJ^L6U9V/&J,,78X'R,B M0%5<@NKS]H(8=K-&H(U%STAQN\'R8L"#IS[./;'F_&NK.4CG?\>.-4B1_LK;^=N@(JI@GK?(0)"0I2C\!['E'D$B@_J:;4#B50 M1>M8@P%-W,8@_C&X,O'#IQG:9<_*O<2SJ>UC[>][BP/C9;6M6L<\P/Y%Y.*L M_P#)WU=X]Z=<;(_^KV:1%RD!!M&B0E9BW;T:-\H$G0]P($RKXC[.#TMXSY#\ MG^#/K2R"4CEVZF7QD=GCF45@9)`S=2(&O*(69.5`62QDC((RI1.(B`IB'

&^I'JQS02D'-DDRE MA,@)+2!D[&5F(NI>(Z`$D^,\/6MSISRY*.>+UZYI9=RDV6$DY%?/[O6JQ8:- M*7RCM85&35-8`$R:PEL/']_V_)D_Q+[A# ME[B+D$`JS#J;WT)'M'4:UY\_E%_'CF/%XSZO['P#?.(>FLJ*F5CY4\&8,/)\ MSL4^;'*91%,"FLT492/2D/0BUP1:WQ]OM'M'C6N1[/^)5"R6>D^0U MHWCG-2N/^G7-977LXXX6(DO5ZE;IF/%P:UEI[J29A#5R^2;)8LFLD1RFA*N" M*"F(.O\`'G?*=FAAD.?/E;FNV2R?N1XY)"'P*@:@'H0O3K;K7Z1_Q-]:N3.>F>=Z@[3@,VW;CR"$033PQM?ZJ[BMM,,W_P6T9F9D_\`J9(LO_BN;WMU4:>^O4O.#Z[9N%+'_(#UKXIP M?C@OW[;L#_O%?%(6C9<@7%_PB647L>TTRB+XU^ZCDO&LHC0-NR3@7D*H%23S M?`(QD%HBH@Q"E*P9*U-=5RU$43B0Q`M2)2&+V%$/D.K1'MG,]T3MR\F+;<0B MWEPK=T7Q`;P/CU\:\NY?JA_`OTJD?.X9Q_?O4GF)U^NWJ4)B-(->XQR+^(=W MZCANXM=6/6L^Y%Z).%],D26S8PTGE#?E3"ZD[%LUSDG,<^?&,!SK#78)RQ2< MI'4#OX2#F1\@'L M^08!V'A/^+X=Q51VQXVTXL43HG]OGL'<>\H8[WU'2F'0O#/BQ5SU)>H\?2[UGX69"T4\ M.5ES3P2QOU4PR2-&+-9UL@".`R=I`(DTDF"9?$`[!W_,1_H`?^NGS'N-9LB" M-!&/RJ+#X#VUV=D;"=)3S2%0A%1) M;N+\(W_F2SMQ\0S/C*7E4R*K*@N2UF(-K`ZB]O$5&;AN^'M7:/-3X^>KDA*0*= MPA9:?9M'[!9RFHW6<$-W,B/NK.'([F]G7%3)JEL^OYYNC* MGVB3KL"[0JN8N[U9*=8[?+1=>J5?N%8N)1PX;-$(U&_5-5^LZ>*D0:-DF:ZJ[,3$17XQ[-3TI'0 ML/&H'=2,M+OFL;&,&R?;['+U^]50:-$"=_DZARE#\^OF%9C9`2Q\!2Z#4]*M M&/T;,[#)H0D3>Z3-S$BT5ECJ/;8C77Q!TJ]52)MFYC)(F$B M"1Q(W;%(43E(0Q@122[II^1Q#L4!$`$?ZATU9W`L"-3U)M;W]#73J'_$]RP\ M=;_\_P`*4Z3W(\:EN2$KPZB\MY52G*2"9JR,EAS3"W;2UMHI&$:64TN$E+6" M,IBL,:`?H.TW9)0S99%8@IG.(]NK\/3?D)X\O*Y9\"/CSMVC(DG'9W7L58+= MPUP18J+6U%0YWS$&<=LM*V>.X\&=F)')M65_I9$+B2)R.MF'B/$$!AKIH:=8>XXV7(\*%A.AL592K+\ M^OV?\M3%?R#*,8N9&0>-(]BR;G=O'KYPBT9LVJ)?L7JX$D=A%'O6DROI\:LJ)U;,9Y[&1L'HM#F9&;!4T,P MB;A7)%[+%03,LN:,:LY)9P_*BB43G%(I_$H"(_'7W?%S(D#S0R(OM*D#YD5R M'1C96!/QKTS6E9Y6Y08.PWNFP4R5%JX-$S-J@(N3*@^6,W8K#'OY!N\!)ZN0 M2)&\/%0X"!1$0[=)'CY,P+01NZCJ0"0/C8&E+*OYB!>JC8+G4:F#`;59Z]60 ME5S-(P;#-Q<*$B[*D=<[1B,FZ:_JW2:)!.9-/R.4H=Q#M\]$4$^0W9CHTDGL M4%C]P-!95%V(`KK1O%,<5H]S;VRLKU!)-=96THS\2K7$DFRIF[E52=(\-%)I M-W)!3.85@*10!*(@/QTGE3"3RF1A*?TV-_EUH)`'<2.VK7';\:%HH_)K>8F8 MHJBBL]+?JD+1)4I@*9-1P,P5$BA#"`"43=P$?PZ<#;MRO;Z::][?D;K_`-VN M?-B'5E^8J^(&Q0-IC49BM3<18H=R98C>6@I)E+QBYVZQV[A-%]'N'+54Z#A, MQ#@4XB4Y1`>P@(=-I(I87,N*6DT^^SBW_'F#?D)G`M"D_<2SV5).Y6>9L%!#[2NIN@N)=DF!!`PK+I]N MX@`=:9Z/=QV.6("\B?C'O[ M=;?*](BYJ:[;O:]Z9>+UYR].,FMVXTXM.-CG_`/&K!$PJ MC55(T;8=5D%)>T-BK")N2*>)QHY$0WM`J M7KTMC;]')UNM9Y7>8N]M2)B=FRV6FFF,NRVD.?H6*1)1OML9:+,@FH4?`U,: MG[=E2".18]2^O6.8KT%(V&J7O&'%8GW\6T=2];< M2.FUN*D7$+)G0-(1AGT8\507^DY?M24,4P"`]NK!_'J3(C]4<6.&1EB>"<,` M;7`B9K:?]F_QL;CK3;FOE_X&5BH)[EM\Z^TG%<_Y4ZUQ^XY:MP.A<-IN><9, MEY491R.6K6/C>++M>6Z1A[J--GEHS=Y80K\=`M%C!.QTJNF[EFTT3S:II)`< M[7<]RS-@P<[>L#>6GRI]QFPI\8--V^3,,@,)!(;-HKM53(*D*8AO'R(%3N4`^'*ILRF-O@18TFG_5_IU1B/4UC]KBZO78RT6N[;"I:;*Q MAHYG/6,\;I5AC8TT],(-TY"7&/CFB+=#]0HI]2*1"%[%*`=:I_(.?(D]3,R% MF?Z=8X2JL[.%#PHQM?H23=O?[:KO"NW_``*,JA;R/T]S$5L'2D;$3\:^A9F/ MCIJ(DD%H^4BI-HUDHU^T7*9%TR?L72:S5TW63$2J)J$,4P"("'6)I(8V`0E9 M18CV]>O^PU:K*X*FS+X^(K5__P!9W-\^A*I[$9V&H]3BYV)Y_:]2(N<8P$8W MF8ZEP;.+/#5%A*D;`_9UJ+,X4%!DDH1ND90P@3N8PCOGKYFYN5)Q\33S/`^Q M02,IIL+]!5.X;#$GUK)&@D&4RW]PM]VM;2!%4SF,4ARF, M0>QRE,41*(@4P`8`$1*(E,`_/]!ZP7V>\7'PJXA@U[>!M6G%;+)9ZC_MAWB> MJ&=3NJ333C+'E)2ZS-T^OSS]LOQZK)'3J.?7N>K%8459E`HBBN^;BH41$IA$ MOB;U+!!CY'\:(\?*G3&C;<">]@[#_>7'1%9KCKTZ5G\CO'STLB%V^FZ"W]OO ML/OICG#?@URLL?MHY(>T[D?28'CQ!7K+V>+95@T?>H/0KU)P+"+HD&G;=.FZ M4N_I,>L+&BE<$9-7K\Y7+HI/,A&I3KYSR7EG'X/3;`].-DE;-GQLULF7([&2 M,%@P[(@X#G\QN64#\(/CI-X.VY;[]+O.6HCB:,*JW!;WDV)`Z>VL1^QV>F.4 MWN=]?GK5T*2>I\47.<63D_K><)N%64!N]CJ+?2Y&IT^^)(G3_DU,A'>>('4B M5A.R,CNN5-2V6*4I5IKC>,DH%A,,HP\8Z:)*`V<-G'B9,3%3$M9]) M][W+'YO@X.7*^7A;ED+CY43Y%CP#:)IXP MJ3Q+W(PZ@CP\#8]-#]X%25]86_W'EIZ\>*6\:HDF[O.FY#&+WI=1D@W;V"?B M7,C4YN=/'`F#0C:UN(4[X4BD!$2NNQ2@3L'5>]0-EQ>-K M0526C:W#LE:M"25&B@9&EA\?NTJ>WN%X. MX=S;S?"]I`$86NC$$W^&FM*2J6XVZU<:N87IC]I<+7+#RMP;`KQ8\ M#U&TLV\K#\GLBI]:D)JGZ%3):8;`Y7TBK1L,`_>DH$FZ:MU#*_\`/8R(CHV= MM$&!O6U>KGIW))'QG+RU$\,3$/ASL5$D3]M[1EF(C-[6L";%:@8\T_23\>WP M#ZV.,E&/255!(*GKW`+<^W[#6S!N?%S--XXTV_BP_B8ZIY)>JY$TR8KU:BF< M='(TAO*Q+V6K,;&L`8M(YK,1$>HP$R/UBW(N*A`\B@`X%MF\9NV;Q'OL#%L^ M&4NKN2Q[O`Z^%Q>Q\>M6^;&3(Q/IK=L;*H-M+``=/ATK7>U[C?Q[KO\`L<<) M<;K^%X]#Y(?U^:057,6.:4QO071FJNV)MEGU33A0@W[E(C5(H*K(**]DR_W? M`=;CM6^;RWH=O.YRYF8=P;?,>TOG/WKVA'-C?J2PUO?KXU5Y\7%CY;BXXB3R MOIFTL+:=WA:VEJV+N+W&;.N)69.,=R*.:0&:M[_HUVJ52CF*,?$TIEH]SEKR M^J,$V0$Q$X&&F)QR1D3^WZFQB)%*!4RAUB6][QG\@SO\EN;M)GF*)'=F+,YB M54#$G4GM4=?&K3A8L6'`8(`%A[BR@>`8]UOF:D;U%T[KROF;619.X]\V0>,7 MS99F]9N4B+MG;1RF9%RV<(J`9-5!P@-1;0W\-:+* MP*MJI%J53ZS?5IG'KUQ_D-DR#N-O+/>=JTVVRJZC%TFU3R.:9-T_-( MP!]@"@#QJ$V?8X-HQ9,<68S,Q)N>AZ#W:$]*KWJA];M<]9F`7''8V?9W&:N. MS:)HDC:FS1VU^RM2,NM&YE6O%\(KE-5,^8LD7(%`$#RJSU9/N5;R'X>H7.\S MG^\Q;KD*8XH<6.%4L!JH!D8D#4O(6:YN0"%%@H`^FR[3%LV*V/%^N1F.I/4Z M#7I\/^FO'[<.#VR>Q7BY*\4\XT+-\KK-VGZO-W>Z76OVBUS;9*FS[&R1$;5X M*">P[`32$G'I@Y;,P`5C:PU-M1:DWS;)=WP?HHV5%+`DGKIK:O'?,%]E]DQ2JX?0MWXKXPD MVJE?SNTZU4\[U:P:)N>2[RM(L32QB+N))7S.R,,P#&Y`(OXZ7%++!NQQTQX)85 M8)VENQKVMX7)%[ZD'PT!&A$S-8RJTK\;9_#L,)38%RZS1WE%9-?E;([KT!6G M57<5%NZ!?L'X$\'Z M_P`/<+V_B6^F*PZO+J`V"\9EKY;5MHP,:2$NK$W(/ZC8WO2JI3FZ4 MI=+XYE4&>@:=(F/,7F]VMQ'-W\JBI=;G(OY1P5!(QDSNO`@%(4.V:[EEXVY[ MQ+EJCP8+2GM1;$I$#^W&";`]B!5O^JU^IJ^<9^^+_`%.\N%6/ MLOY=SJ/,[KZW\*@5V7-7?COADB[63L*!3?ML!H;WOIUM;W5L%H@H"9/M\?M\ M"?9X>0D^SM_?X"8`,)?+\._SVZQ@=-+D7-K]?MJS^%+-YT>N]+E!I_'?E)D. MCAAG,#B?8'DMD&G.JT-QI]CKDN*H67*]9J*,E!24_0K(@LX2\V4@S>Q_ZUP= M$QOM.0UTXMS+_P#/8&;L6XP',XUN*@2Q!BC*X_)+&P#69#J`5*M8`V&M1.X; M6N=-%F1.T>="3VM8=/$$'2Q_I5C\L>*/-CG?CJG&+7=%PCCYB-]+$->0-@PE M;0]%U;0JS&2+64?T.AKW^LTBMYC$6A=DFF]D'!;"Z*U$Z!$A`QS'<\7Y%QSA M^ZC?-MQLK,W+%8-BK.R1Q(YO^.7L):7L_2JLFHN3T%)G;?F[ECMB9#11P/;N M*W)('A8V']?E>F)YSDU8PK&:=C6+0$57:KEM$C:3F]>=KOAB6#"MPY8RO-)5 MXB1S)+HF,@07;@"J.%3&.H(&./S2\_,RMWW.7U9.!FY.7(Z,N0_ M<0+BW7Y]:E!R\Q3E9L=WP&4Q2YX13:KAVPUW:W*&DUJ^V6?NTU"5J[U%:G"I M6Y.'C:O`.XFZJJ_N!`?NRN4R=D@(4Q5(/C>[;#M>+G)NL69-D9>(T">6Z(L9 M9T?O/ZB_L4 MM>&SDC:)M9!NISHMT8IPS)^E*F)S_894FDX?,-FQO3O+X$'MMX#IX5)+J.IU7__9 ` end